The Rx Consultant for Pharmacology Ce Aanp Reviews
Action Duration
Expires: | August 15, 2022 (11:55 p.m. CT) CE for this activity will not be available after this date. |
This CE action was recorded for the 2021 AANP Autumn Conference.
This activity includes closed captioning. |
Commitment Note:The content for this activity was previously presented during the 2021 AANP Fall Conference. If you already completed the content of this activity while attending the alive or virtual briefing, you should non consummate this content a second time. Learners should simply complete Ane delivery-method to earn credit. Completing multiple commitment options for the aforementioned activity is considered indistinguishable credit for the same content and will not exist accepted by regulatory bodies.
Dr. Angela Aureate has the post-obit disclosures related to obesity:
Overview
70 percent (lxx%) of Americans have pre-obesity or take the serious, chronic and relapsing disease of obesity. This presentation will review the current medication options including off label, obesogenic medication alternatives for treating obesity. A instance study arroyo will be utilized to demonstrate medication choice. Additionally, a look at what is alee for the handling of obesity will conclude the presentation.
Objectives
Speaker
Dr. Angela Aureate, DNP, FNP-C, FAANP
Disclosure
This program was planned in accord with AANP CE Standards and Policies.
- Novo Nordisk: Speaker's bureau and Consultant
- Unjury, Consultant
- Gelesis, Consultant
This didactics may contain opinions of the authors from their personal experience. The activity may contain discussion of published and/ or investigational uses of agents that are non indicated by the FDA. Delight refer to the official prescribing information for each product for give-and-take of approved indications, contraindications, and warnings. Further, attendees/ participants should appraise the information presented critically and are encouraged to consult appropriate resources for any production or device mentioned in this program.
Disclaimer
Individuals who have contributed to the CE Center (content originally from the 2021 AANP Fall Briefing) were carefully selected for their knowledge and experience in the subject surface area nether review. This presentation is informational only and may contain opinions of the authors from their personal experience that do non necessarily express the opinions of the American Clan of Nurse Practitioners (AANP). The activity may incorporate discussion of published and/or investigational uses of agents that are not indicated past the FDA. Please refer to the official prescribing information for each product for give-and-take of approved indications, contraindications, and warnings. Clinical practice is a constantly irresolute process and new data becomes available every day. Neither AANP nor the contributing individuals can warrant that the material volition continue to exist accurate, nor practice they warrant that the material is completely complimentary of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult advisable resources for whatsoever product or device mentioned in this program.
CE Credit Instructions
Additional Information
For questions or more data concerning this CE Center activeness, contact AANP CE Center Support at cecenter@aanp.org .
teichelmannsiled1978.blogspot.com
Source: https://aanp.inreachce.com/Details/Information/0883f22c-2c9c-478e-aecf-ec4307ff028b